Anpario (LON:ANP) Stock Price Up 10.9% – Here’s What Happened

Anpario plc (LON:ANPGet Free Report)’s stock price traded up 10.9% during mid-day trading on Friday . The stock traded as high as GBX 415 ($5.07) and last traded at GBX 407.66 ($4.98). 152,837 shares were traded during mid-day trading, an increase of 273% from the average session volume of 40,994 shares. The stock had previously closed at GBX 367.50 ($4.49).

Analyst Ratings Changes

Separately, Canaccord Genuity Group lifted their target price on Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a research note on Wednesday, September 18th.

Check Out Our Latest Analysis on ANP

Anpario Price Performance

The company’s 50-day moving average price is GBX 357.55 and its two-hundred day moving average price is GBX 320.19. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The company has a market capitalization of £68.94 million, a P/E ratio of 2,264.78 and a beta of 0.58.

Insiders Place Their Bets

In related news, insider Karen Prior sold 14,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.64), for a total value of £53,200 ($64,957.26). Company insiders own 30.51% of the company’s stock.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.